1. Home
  2. REFR vs NTRB Comparison

REFR vs NTRB Comparison

Compare REFR & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

HOLD

Current Price

$1.14

Market Cap

54.8M

Sector

Miscellaneous

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.27

Market Cap

57.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REFR
NTRB
Founded
1965
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Industrial Specialties
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.8M
57.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REFR
NTRB
Price
$1.14
$4.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.1K
16.7K
Earning Date
03-05-2026
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,227,276.00
$2,278,321.00
Revenue This Year
N/A
$30.17
Revenue Next Year
N/A
$3,394.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.69
52 Week Low
$0.93
$4.17
52 Week High
$2.70
$11.68

Technical Indicators

Market Signals
Indicator
REFR
NTRB
Relative Strength Index (RSI) 32.42 41.69
Support Level $1.14 $4.51
Resistance Level $1.32 $4.85
Average True Range (ATR) 0.08 0.29
MACD -0.00 0.00
Stochastic Oscillator 10.49 8.97

Price Performance

Historical Comparison
REFR
NTRB

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: